Buy Clovis Oncology Stock | CLVS Stock Price & Latest News | Public.com
CLVS

Clovis Oncology

$0.00 (0.00%)Today
    View Clovis Oncology (CLVS) stock trends here

    About CLVS

    Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered f...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.38
    -0.77
    -1.15
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.68

    Actual EPS
    Q1 2021

    Stats

    Market Cap$550,22M
    Volume468,71k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.10
    1 Year Low$3.62
    Open$6.29
    High$6.35
    Low$6.20

    Buy any stock with any amount of money.

    Download the App
    Download the app